Published in J Virol on August 01, 2001
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol (2002) 5.82
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol (2006) 2.94
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J Virol (2003) 2.93
Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J Virol (2006) 2.79
Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. J Virol (2006) 2.63
The AAV vector toolkit: poised at the clinical crossroads. Mol Ther (2012) 2.53
Structure of adeno-associated virus serotype 8, a gene therapy vector. J Virol (2007) 2.15
Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J Virol (2006) 1.97
Treatment of human disease by adeno-associated viral gene transfer. Hum Genet (2006) 1.84
AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther (2005) 1.80
Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. J Biol Chem (2011) 1.73
Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther (2009) 1.73
DNA shuffling of adeno-associated virus yields functionally diverse viral progeny. Mol Ther (2008) 1.70
Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups. J Virol (2004) 1.64
Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry. J Virol (2006) 1.64
Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J Virol (2007) 1.60
Adeno-associated virus: from defective virus to effective vector. Virol J (2005) 1.60
Structure of adeno-associated virus serotype 5. J Virol (2004) 1.50
Structure of adeno-associated virus type 4. J Virol (2005) 1.47
Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol (2004) 1.45
Recombinant adeno-associated virus transduction and integration. Mol Ther (2008) 1.44
Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther (2012) 1.44
Adeno-associated viral vector serotype 5 poorly transduces liver in rat models. PLoS One (2013) 1.44
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors. PLoS One (2013) 1.33
Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng (2008) 1.28
Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain. Mol Ther (2009) 1.28
Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3. Hum Gene Ther (2010) 1.26
Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses. J Virol (2003) 1.24
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production. J Virol (2003) 1.24
Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex. Virology (2009) 1.23
Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview. Glycoconj J (2006) 1.21
The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion. Virology (2010) 1.21
Viral vectors for gene delivery to the central nervous system. Neurobiol Dis (2011) 1.20
Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Mol Ther (2008) 1.20
Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog (2011) 1.19
Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther (2005) 1.19
Gangliosides are essential for bovine adeno-associated virus entry. J Virol (2006) 1.17
Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 1.17
Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors. Hum Gene Ther (2005) 1.17
A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia. Proc Natl Acad Sci U S A (2005) 1.17
Comparative analysis of adeno-associated virus capsid stability and dynamics. J Virol (2013) 1.16
Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors. J Virol (2004) 1.15
An N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor for BK virus. J Virol (2005) 1.15
Role of recycling endosomes and lysosomes in dynein-dependent entry of canine parvovirus. J Virol (2002) 1.14
Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks. J Virol (2006) 1.13
Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J Virol (2002) 1.13
Changes in adeno-associated virus-mediated gene delivery in retinal degeneration. Hum Gene Ther (2010) 1.10
PKA/PrKX activity is a modulator of AAV/adenovirus interaction. EMBO J (2003) 1.08
Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J Virol (2006) 1.07
Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo. Hum Gene Ther Methods (2013) 1.06
Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence. J Virol (2006) 1.05
Glycan binding avidity determines the systemic fate of adeno-associated virus type 9. J Virol (2012) 1.05
Biology of adeno-associated viral vectors in the central nervous system. Front Mol Neurosci (2014) 1.04
Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector. Gene Ther (2011) 1.03
Adeno-associated virus: a key to the human genome? Future Virol (2010) 1.03
Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid. J Virol (2012) 1.03
Sialic acid functions in enterovirus 70 binding and infection. J Virol (2002) 1.01
Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. Ann Rheum Dis (2005) 1.01
Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking. J Virol (2013) 1.01
Capsid antibodies to different adeno-associated virus serotypes bind common regions. J Virol (2013) 1.01
AAV9 targets cone photoreceptors in the nonhuman primate retina. PLoS One (2013) 1.00
Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines. J Virol (2005) 0.99
Current status of gene therapy for inherited lung diseases. Annu Rev Physiol (2002) 0.98
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.96
Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.96
Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells. J Virol (2007) 0.95
Efficient cochlear gene transfection in guinea-pigs with adeno-associated viral vectors by partial digestion of round window membrane. Gene Ther (2011) 0.94
Recombinant AAV9-TLK1B administration ameliorates fractionated radiation-induced xerostomia. Hum Gene Ther (2013) 0.93
Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome. Arthritis Res Ther (2009) 0.93
Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5. J Gen Virol (2011) 0.93
Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus. Biochemistry (2013) 0.93
Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942). J Virol (2008) 0.92
Structural insights into adeno-associated virus serotype 5. J Virol (2013) 0.92
Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome. Arthritis Res Ther (2012) 0.92
Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus. J Virol (2012) 0.91
Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans. J Virol (2013) 0.91
Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy. Arthritis Res Ther (2012) 0.90
Parvovirus glycan interactions. Curr Opin Virol (2014) 0.90
Pathways of cell infection by parvoviruses and adeno-associated viruses. J Virol (2004) 0.89
Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.89
Methods for gene transfer to the central nervous system. Adv Genet (2014) 0.88
Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4. J Virol (2013) 0.87
Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy. Hum Gene Ther (2015) 0.87
Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCAD. Hum Gene Ther (2008) 0.86
Viral vector tropism for supporting cells in the developing murine cochlea. Hear Res (2011) 0.85
Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity. J Virol (2014) 0.85
Comparative analysis of the transduction efficiency of five adeno associated virus serotypes and VSV-G pseudotype lentiviral vector in lung cancer cells. Virol J (2013) 0.84
Enhanced sialic acid-dependent endocytosis explains the increased efficiency of infection of airway epithelia by a novel adeno-associated virus. J Virol (2011) 0.84
Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid. Virology (2013) 0.83
TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice. Oral Dis (2011) 0.82
Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One (2011) 0.82
Adeno-associated Virus as a Mammalian DNA Vector. Microbiol Spectr (2015) 0.82
C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice. J Virol (2013) 0.82
Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells. J Virol (2011) 0.82
Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors. Curr Gene Ther (2012) 0.81
An adeno-associated viral vector transduces the rat hypothalamus and amygdala more efficient than a lentiviral vector. BMC Neurosci (2010) 0.81
Adeno-associated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transduction. Hum Gene Ther (2012) 0.81
Identification and mutagenesis of the adeno-associated virus 5 sialic acid binding region. J Virol (2014) 0.80
AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci (2011) 0.80
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol (1998) 8.45
Intracellular functions of N-linked glycans. Science (2001) 8.39
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med (1997) 6.57
Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol (1998) 4.71
Gene therapy vectors based on adeno-associated virus type 1. J Virol (1999) 4.63
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A (2000) 4.39
Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science (2001) 4.13
Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science (1993) 4.12
Serologic evidence for human infection with adenovirus-associated viruses. J Natl Cancer Inst (1968) 3.44
Cloning and characterization of adeno-associated virus type 5. J Virol (1999) 3.36
Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem (2001) 3.15
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol (2000) 3.00
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol (1997) 2.91
Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem (1997) 2.69
Diversity in the sialic acids. Glycobiology (1992) 2.60
Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology (1984) 2.49
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology (1996) 2.26
Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum Gene Ther (1998) 2.00
Complementation between mutants of CHO cells resistant to a variety of plant lectins. Somatic Cell Genet (1977) 1.98
Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol (1999) 1.94
Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J Virol (1998) 1.80
A genome-linked copy of the NS-1 polypeptide is located on the outside of infectious parvovirus particles. J Virol (1989) 1.78
Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes. J Gen Virol (1979) 1.70
Resialylated erythrocytes for assessment of the specificity of sialyloligosaccharide binding proteins. Methods Enzymol (1987) 1.65
Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology (2000) 1.62
Sialidases: structures, biological significance and therapeutic potential. Curr Opin Struct Biol (1996) 1.55
Differences in attachment between herpes simplex type 1 and type 2 viruses to neurons and glial cells. Infect Immun (1980) 1.53
Purification and properties of cloned Salmonella typhimurium LT2 sialidase with virus-typical kinetic preference for sialyl alpha 2----3 linkages. J Biochem (1991) 1.50
Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. J Virol (1996) 1.44
Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid. Virology (1995) 1.37
Mutations adjacent to the dimple of the canine parvovirus capsid structure affect sialic acid binding. Virology (1992) 1.33
Newcastle disease virus contains a linkage-specific glycoprotein sialidase. Application to the localization of sialic acid residues in N-linked oligosaccharides of alpha 1-acid glycoprotein. J Biol Chem (1982) 1.29
Hemagglutinin of type 4 adeno-associated satellite virus. J Immunol (1968) 1.27
Enzymatic properties of neuraminidases from Arthrobacter ureafaciens. J Biochem (1979) 1.20
Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport (2000) 1.20
Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes. Virology (1980) 1.10
The release of N-acetyl- and N-glycolloyl-neuraminic acid from soluble complex carbohydrates and erythrocytes by bacterial, viral and mammalian sialidases. Biochem J (1981) 1.08
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A (2000) 4.39
CliniWeb: managing clinical information on the World Wide Web. J Am Med Inform Assoc (1996) 4.13
Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem (2001) 3.15
Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem (1999) 3.04
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol (2000) 3.00
Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nat Immunol (2001) 2.83
Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev (2000) 2.55
Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest (1998) 2.51
A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest (1995) 2.48
Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev (1998) 2.37
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology (1996) 2.26
Detection of influenza A(H3N2) virus in children with suspected mumps during winter 2014/15 in England. Euro Surveill (2015) 2.19
Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology (1996) 1.97
Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol (1999) 1.93
Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab (2010) 1.90
Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J Bacteriol (1995) 1.74
Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J Gen Virol (2000) 1.73
Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med (1995) 1.70
The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill (2012) 1.67
Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis (1997) 1.63
Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem (1997) 1.57
Inhibitory action of fatty acids on the growth of Neisseria gonorrhoeae. Infect Immun (1977) 1.53
Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol (2001) 1.52
Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest (1999) 1.46
Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J Virol (1997) 1.46
Fabrication of an ocular prosthesis. J Prosthet Dent (1970) 1.32
Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci U S A (1996) 1.29
The interaction of heparin sulfate and adeno-associated virus 2. Virology (2000) 1.28
Augmentation of lung liquid clearance via adenovirus-mediated transfer of a Na,K-ATPase beta1 subunit gene. J Clin Invest (1998) 1.27
Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection. J Clin Invest (1994) 1.26
Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood (2000) 1.25
Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum Gene Ther (1999) 1.25
A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology (1999) 1.25
Regulation of gene expression for translation initiation factor eIF-2 alpha: importance of the 3' untranslated region. Biochem J (1996) 1.24
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood (2001) 1.24
Clinical considerations improving obturator treatment. J Prosthet Dent (1970) 1.23
An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther (1989) 1.22
Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport (2000) 1.20
Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo. Am J Respir Cell Mol Biol (2000) 1.18
Mini-chromosomes derived from the human Y chromosome by telomere directed chromosome breakage. Proc Natl Acad Sci U S A (1996) 1.18
Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression. Am J Physiol (1995) 1.17
Enhanced transduction of mouse salivary glands with AAV5-based vectors. Gene Ther (2006) 1.17
Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci (2006) 1.16
Rhesus and pig-tailed macaque parvoviruses: identification of two new members of the erythrovirus genus in monkeys. Virology (2000) 1.15
Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol (2007) 1.15
Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS. Gene Ther (2005) 1.14
Fabrication of a hollow-bulb obturator. J Prosthet Dent (1969) 1.14
Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem (1989) 1.13
Reconstruction considerations for severe dental attrition. J Prosthet Dent (1980) 1.11
Integrin alphaVbeta5 is not involved in adeno-associated virus type 2 (AAV2) infection. Virology (1999) 1.08
PrKX is a novel catalytic subunit of the cAMP-dependent protein kinase regulated by the regulatory subunit type I. J Biol Chem (1999) 1.07
Retracted GB virus C/hepatitis G virus replicates in human haematopoietic cells and vascular endothelial cells. J Gen Virol (2000) 1.07
AAV2-mediated transfer of the human aquaporin-1 cDNA restores fluid secretion from irradiated miniature pig parotid glands. Gene Ther (2010) 1.06
Peripheral consideration in improving obturator retention. J Prosthet Dent (1968) 1.04
Reliability and validity of four instruments for measuring lumbar spine and pelvic positions. Phys Ther (1986) 1.04
Adeno-associated virus 2 co-receptors? Nat Med (1999) 1.04
Engineering novel cell surface receptors for virus-mediated gene transfer. J Biol Chem (1999) 1.03
A key transcription factor for eukaryotic initiation factor-2 alpha is strongly homologous to developmental transcription factors and may link metabolic genes to cellular growth and development. J Biol Chem (1994) 1.03
A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia. Gene Ther (1997) 1.02
Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion (2000) 1.01
Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis (1998) 1.00
Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. Blood (2001) 0.99
Gene transfer using bovine adeno-associated virus in the guinea pig cochlea. Gene Ther (2009) 0.98
Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol (1997) 0.98
Isolation and characterization of the promoter and flanking regions of the gene encoding the human protein-synthesis-initiation factor 2 alpha. Gene (1989) 0.97
Adenovirus-mediated gene transfer for cystic fibrosis: Part A. Safety of dose and repeat administration in the nasal epithelium. Part B. Clinical efficacy in the maxillary sinus. Hum Gene Ther (1995) 0.97
Adherence of human basophils to cultured umbilical vein endothelial cells. J Clin Invest (1988) 0.96
Aging effects on the elastin composition in the extracellular matrix of cultured rat aortic smooth muscle cells. In Vitro Cell Dev Biol (1985) 0.96
Efficient killing of inhaled bacteria in DeltaF508 mice: role of airway surface liquid composition. Am J Physiol (1999) 0.96
Clinical and epidemiological features of simian parvovirus infection in cynomolgus macaques with severe anemia. Lab Anim Sci (1996) 0.95
Gender differences in serotype 2 adeno-associated virus biodistribution after administration to rodent salivary glands. Hum Gene Ther (2007) 0.95
Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C. J Virol (1999) 0.95
Fabrication of a nose prosthesis. J Prosthet Dent (1971) 0.94
Paraoxonase 1, quorum sensing, and P. aeruginosa infection: a novel model. Adv Exp Med Biol (2010) 0.93
AAV5-mediated gene transfer to the parotid glands of non-human primates. Gene Ther (2009) 0.93
Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome. Oral Dis (2011) 0.92
Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumourigenic colon cancer cell line. J Pathol (2000) 0.92
Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest (1995) 0.90
Fabrication of orbital prosthesis. J Prosthet Dent (1969) 0.90
Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndrome. Ann Rheum Dis (2010) 0.90
Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol (1992) 0.89
The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo (1991) 0.89
Evaluation of in vivo total and regional air content and distribution in primate lungs with high-resolution CT. Acad Radiol (1997) 0.88
Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo. Hum Gene Ther (1998) 0.88
Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia. J Clin Invest (2000) 0.87
Keratinocyte growth factor induced epithelial proliferation facilitates retroviral-mediated gene transfer to distal lung epithelia in vivo. J Gene Med (2000) 0.87
Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet (1989) 0.87
Differential mRNA regulation of integrin subunits alpha V, beta 1, beta 3, and beta 5 during mouse embryonic organogenesis. Cell Adhes Commun (1995) 0.87
Delivery of an adenovirus vector in a calcium phosphate coprecipitate enhances the therapeutic index of gene transfer to airway epithelia. Hum Gene Ther (1999) 0.87
Detection of B19 parvovirus in human fetal tissues by electron microscopy. J Med Virol (1991) 0.86
Regulation of eukaryotic translation initiation factor expression during T-cell activation. Biochim Biophys Acta (1993) 0.85
Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system. Gene Ther (2003) 0.85